Skip to content

Ropivacaine versus bupivacaine plus lidocaine in peribulbar blocks

A prospective, randomized, triple-blind comparative study of ropivacaine with bupivacaine plus lidocaine mixtures used in peribulbar blocks for cataract surgery - RVBL

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2021/08/035884
Enrollment
90
Registered
2021-08-24
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: H251- Age-related nuclear cataract Health Condition 2: O- Medical and Surgical

Interventions

Intervention1: Ropivacaine 0.75%: six ml of 0.75% Ropivacaine in 2 divided doses of 4ml and 2ml at infero temporal and superonasal quadrants of the eye ball respectively given once Control Interventio

Sponsors

Gayatri vidya parishad Institute of health care and medical technology
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Inclusion criteria for our study consist of both male and female patients with an age range between 40 and 80 years and are of American Society of Anesthesiologists (ASA) physical status grades I and II attending our medical college hospital for elective cataract surgery

Exclusion criteria

Exclusion criteria: The exclusion criteria for our study include patients with known allergy to study drugs, those refusing the regional block, those on anticoagulant therapy, high myopia (axial length of eyeball > 28 mm), previous ophthalmic surgery such as buckling surgery, glaucoma, posterior staphyloma, ocular infection, orbital anomaly, mental retardation, uncontrolled hypertension & diabetes mellitus, and chronic obstructive pulmonary disease.

Design outcomes

Primary

MeasureTime frame
The primary outcome measures observed will be the duration of the onset of the motor and sensory block and total duration of the sensory block.Timepoint: Onset of motor and sensory block will be tested at every minute starting one minute from the administration of the block till the time when total akinesia and analgesia of the eyeball was achieved. Total duration of the sensory block will be measured by the time elapsed from the onset of sensory block to the time when pain is reported by the patients for the first time in the postoperative ward.

Secondary

MeasureTime frame
Alterations in mean arterial pressure (MAP), pulse rate (PR), respiratory rate (RR), saturation of arterial oxygen (SaO2), adverse drug effects, total analgesic requirement in the first 24 hours after surgery, Ramsay sedation score(RSS), surgeon and patient satisfaction scores and other complications encountered were the secondary outcome measures studiedTimepoint: starting 1 minute from the administration of the block at1 minute interval upto 10 minutes and there after upto first 24 hours of completion of surgery

Countries

India

Contacts

Public ContactRamana Reddy MV

Gayatri Vidya Parishad Institute of Health Care and Medical Technology

drramanareddymoolagani@gmail.com9908232415

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026